Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-02
2006-05-02
Spivack, Phyllis G. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S251000, C514S458000, C514S474000, C514S553000, C514S616000
Reexamination Certificate
active
07037934
ABSTRACT:
A blood lipid ameliorating composition containing atorvastatin in combination with an agent selected from the group consisting of a riboflavin derivative, a tocopherol compound, an ascorbic acid derivative, pantethine and taurine.
REFERENCES:
patent: 5662934 (1997-09-01), Najarian
patent: 933080 (1999-08-01), None
patent: 55-76816 (1980-06-01), None
patent: 58-69813 (1983-04-01), None
patent: 60-41611 (1985-03-01), None
patent: WO 94/15592 (1994-07-01), None
patent: WO 97/38694 (1997-10-01), None
Faggiotto et al., Current Opinion in Lipidology (1998) 9/6 (541-549) (abstract).
Aviram, et al., “Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation”,Atherosclerosis, 138, 271-280 (1998).
Kondo Tatsuhito
Nakayama Masato
Ohsawa Tsuneki
Shimizu Ippei
Takagi Ikuo
Frishauf Holtz Goodman & Chick P.C.
Sankyo Company Limited
Spivack Phyllis G.
LandOfFree
Blood lipid ameliorant composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Blood lipid ameliorant composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blood lipid ameliorant composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3575719